Re:Cognition Health starts Alzheimer’s Trials

Recognitionhealth-logoRe:Cognition Health based at Plymouth Science Park is to start Clinical trials of Axovant’s RVT-101, a compound in development to treat Alzheimer’s disease.

The last drug to be approved to help improve Alzheimer’s patients’ cognition was Donepezil in 2002 so the findings of this trial could be huge. If approved, the drug could be the first approved Alzheimer’s treatment in 14 years.

Re:Cognition Health is the only facility in the South West of England to begin the clinical trial.

Read the full story here…

 

 

FacebooktwitterlinkedinmailFacebooktwitterlinkedinmail

Upcoming Events

  1. Science and Technology Showcase – 23 & 24 January

    23rd January 2019 - 24th January 2019
  2. PEMC Industrial Solutions Event Series

    7th February 2019 - 9:30 am - 1:30 pm
  3. Using Google Ads to drive website visitors and online sales

    8th February 2019 - 9:00 am - 1:00 pm
  4. Skills South West Event

    13th March 2019 - 14th March 2019
  5. Spring Placement & Graduate Careers Fair

    26th March 2019 - 11:00 am - 3:00 pm